Details for New Drug Application (NDA): 020148
✉ Email this page to a colleague
The generic ingredient in MIGRANAL is dihydroergotamine mesylate. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
Summary for 020148
Tradename: | MIGRANAL |
Applicant: | Bausch |
Ingredient: | dihydroergotamine mesylate |
Patents: | 0 |
Suppliers and Packaging for NDA: 020148
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MIGRANAL | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 020148 | NDA | Bausch Health US, LLC | 0187-0245 | 0187-0245-01 | 1 VIAL in 1 KIT (0187-0245-01) / 1 mL in 1 VIAL |
MIGRANAL | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 020148 | NDA | Bausch Health US, LLC | 0187-0245 | 0187-0245-03 | 8 VIAL in 1 KIT (0187-0245-03) / 1 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY, METERED;NASAL | Strength | 0.5MG/SPRAY | ||||
Approval Date: | Dec 8, 1997 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020148
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | MIGRANAL | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 020148-001 | Dec 8, 1997 | ⤷ Subscribe | ⤷ Subscribe |
Bausch | MIGRANAL | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 020148-001 | Dec 8, 1997 | ⤷ Subscribe | ⤷ Subscribe |
Bausch | MIGRANAL | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 020148-001 | Dec 8, 1997 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription